Related Experiment Videos
Extracorporeal membrane oxygenation in the newborn
K P Lally1, R Clark, C Schwendeman
1Department of Surgery, Wilford Hall USAF Medical Center, Lackland AFB, TX 78236-5300.
Military Medicine
|August 1, 1990
Summary
Extracorporeal membrane oxygenation (ECMO) offers a vital treatment for newborns with reversible lung disease. This neonatal intensive care technique significantly improves survival rates in critically ill infants.
Area of Science:
- Neonatal Medicine
- Pediatric Critical Care
- Cardiopulmonary Support
Background:
- Extracorporeal membrane oxygenation (ECMO) is a life-support technology for neonates with severe, reversible respiratory failure.
- Conventional ventilation often has a high mortality rate for neonates with conditions like meconium aspiration or congenital diaphragmatic hernia.
Purpose of the Study:
- To evaluate the efficacy and outcomes of an established ECMO program for critically ill newborns.
- To assess the survival rates and complications associated with ECMO in neonatal patients.
Main Methods:
- Retrospective analysis of 57 neonatal patients treated with ECMO from 1985 onwards.
- Patients received ECMO for severe hypoxemia unresponsive to conventional support, with a mean bypass duration of 125 hours.
Main Results:
- Overall survival rate was 79% (45 out of 57 patients).
- Common diagnoses included meconium aspiration, congenital diaphragmatic hernia, and neonatal sepsis/pneumonia.
- Frequent complications were intracranial and surgical site hemorrhages.
Conclusions:
- ECMO is a highly effective adjunct for managing critically ill newborns with reversible pulmonary disease.
- The program demonstrated a significant improvement in survival for neonates with severe respiratory failure.